Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RSP vs MRNA✓SelectedUSD · MRNARSP vs MRNA performance historyLatest closeAs of+0.20%11/13
Stock and ETF performance explorer

RSP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.1%
MRNA return
+221.0%
Excess return
-155.8%
Maximum drawdown
-17.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+0.2%-3.4%+3.6%+0.3%
7D+2.4%-12.1%+14.5%+2.7%
30D+4.3%-1.3%+5.6%+4.2%
3M-0.3%+250.9%-251.3%-5.7%
6M+9.8%+343.0%-333.2%+1.2%
YTD+16.8%+657.4%-640.6%+1.8%
1Y+19.5%+794.9%-775.4%+2.3%
3Y+65.1%+218.1%-153.0%+41.8%
All+65.1%+221.0%-155.8%+41.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling